BioPharma Credit PLC Dividend Declaration (0560F)
November 12 2020 - 2:00AM
UK Regulatory
TIDMBPCR
RNS Number : 0560F
BioPharma Credit PLC
12 November 2020
BIOPHARMA CREDIT PLC
("BIOPHARMA CREDIT" OR THE "COMPANY")
DIVIDEND DECLARATION
BioPharma Credit PLC (LSE: BPCR), the specialist life sciences
debt investor, is pleased to declare an interim dividend in respect
of the financial period ending 30 September 2020 of $0.0175 per
ordinary share and a small special dividend in respect of the
financial period ending 31 December 2019 of $0.0001 per ordinary
share, payable on 18 December 2020 to ordinary shareholders on the
register as at 20 November 2020. The Company has a small revenue
reserve remaining for the fiscal year 2019 that it is distributing
to ordinary shareholders. The Company has chosen to designate the
entire amount of this interim and special dividend as an interest
distribution. Shareholders in receipt of such a dividend will be
treated for UK tax purposes as though they have received a payment
of interest. This will result in a reduction in the corporation tax
payable by the Company.
The Company is currently paying and continues to target a 7 cent
annual dividend per ordinary share.
The default payment for dividends is in US dollars. However,
shareholders can elect to have dividends paid in sterling (GBP) and
the option to elect a sterling dividend payment for this dividend
will be available to shareholders until 20 November 2020 (the
"Election Date").
Further details together with a copy of the Dividend Currency
Election Form, which should be sent to Link Asset Services, The
Registry, 34 Beckenham Road, Beckenham, Kent, BR3 4TU when
completed, will be available on the Group's website shortly at
www.bpcruk.com/investor-materials. CREST shareholders must elect
via CREST.
LEI: 213800AV55PYXAS7SY24
-Ends-
Link Company Matters Limited
Company Secretary
12 November 2020
Enquiries:
Buchanan
David Rydell / Mark Court / Jamie Hooper / Henry Wilson
+44 (0)20 7466 5000
Biopharmacredit@buchanan.uk.com
Notes to Editors:
BioPharma Credit PLC is London's only listed specialist investor
in debt from the life sciences industry and joined the LSE on 27
March 2017. The Company seeks to provide long-term shareholder
returns, principally in the form of sustainable income
distributions from exposure to the life sciences industry. The
Company seeks to achieve this objective primarily through
investments in debt assets secured by royalties or other cash flows
derived from the sales of approved life sciences products.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DIVBBBTTMTBBTBM
(END) Dow Jones Newswires
November 12, 2020 02:00 ET (07:00 GMT)
Biopharma Credit (LSE:BPCR)
Historical Stock Chart
From Apr 2024 to May 2024
Biopharma Credit (LSE:BPCR)
Historical Stock Chart
From May 2023 to May 2024